155 related articles for article (PubMed ID: 8131699)
21. Comparison of the upper gastrointestinal effects of etodolac and aspirin in healthy dogs.
Nishihara K; Kikuchi H; Kanno T; Tanabe S; Sarashina T; Uzuka Y
J Vet Med Sci; 2001 Oct; 63(10):1131-3. PubMed ID: 11714031
[TBL] [Abstract][Full Text] [Related]
22. Nonsteroidal antiinflammatory drug use in patients receiving warfarin: emphasis on nabumetone.
Hilleman DE; Mohiuddin SM; Lucas BD
Am J Med; 1993 Aug; 95(2A):30S-34S. PubMed ID: 8357000
[TBL] [Abstract][Full Text] [Related]
23. A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production.
Laine L; Sloane R; Ferretti M; Cominelli F
Gastrointest Endosc; 1995 Nov; 42(5):428-33. PubMed ID: 8566633
[TBL] [Abstract][Full Text] [Related]
24. Different effects of indomethacin and nabumetone on prostaglandin-mediated gastric responses to central vagal activation in rats.
Cardin S; Soll AH; Taché Y
J Pharmacol Exp Ther; 1995 Nov; 275(2):667-73. PubMed ID: 7473153
[TBL] [Abstract][Full Text] [Related]
25. Non-steroidal anti-inflammatory drug, nabumetone, prevents indometacin-induced gastric damage via inhibition of neutrophil functions.
Ishiwata Y; Okamoto M; Yokochi S; Hashimoto H; Nakamura T; Miyachi A; Naito Y; Yoshikawa T
J Pharm Pharmacol; 2003 Feb; 55(2):229-37. PubMed ID: 12635655
[TBL] [Abstract][Full Text] [Related]
26. A subchronic study of the effect of etodolac on the gastric mucosal prostaglandin levels in the rat.
Lee DK; Cohen R; Gilliar J; Mulder B; Smith T
Agents Actions; 1986 Nov; 19(3-4):228-32. PubMed ID: 2950733
[TBL] [Abstract][Full Text] [Related]
27. Low direct cytotoxicity of nabumetone on gastric mucosal cells.
Arai Y; Tanaka K; Ushijima H; Tomisato W; Tsutsumi S; Aburaya M; Hoshino T; Yokomizo K; Suzuki K; Katsu T; Tsuchiya T; Mizushima T
Dig Dis Sci; 2005 Sep; 50(9):1641-6. PubMed ID: 16133963
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation.
Futaki N; Arai I; Hamasaka Y; Takahashi S; Higuchi S; Otomo S
J Pharm Pharmacol; 1993 Aug; 45(8):753-5. PubMed ID: 8229647
[TBL] [Abstract][Full Text] [Related]
29. Economic and gastrointestinal safety comparisons of etodolac, nabumetone, and oxaprozin from insurance claims data from patients with arthritis.
Simon LS; Zhao SZ; Arguelles LM; Lefkowith JB; Dedhiya SD; Fort JG; Johnson KE
Clin Ther; 1998; 20(6):1218-35; discussion 1192-3. PubMed ID: 9916614
[TBL] [Abstract][Full Text] [Related]
30. Effects of the prodrug nabumetone, and its active metabolite, 6-MNA, on human and rat gastric mucosal prostanoids and platelet function.
Jeremy JY; Mikhailidis DP; Barradas MA; Kirk RM; Dandona P
Drugs; 1990; 40 Suppl 5():53-6. PubMed ID: 2081494
[No Abstract] [Full Text] [Related]
31. In vivo effects of carprofen, deracoxib, and etodolac on prostanoid production in blood, gastric mucosa, and synovial fluid in dogs with chronic osteoarthritis.
Sessions JK; Reynolds LR; Budsberg SC
Am J Vet Res; 2005 May; 66(5):812-7. PubMed ID: 15934608
[TBL] [Abstract][Full Text] [Related]
32. Tissue selective inhibition of prostaglandin biosynthesis by etodolac.
Dvornik DM
J Rheumatol Suppl; 1997 Feb; 47():40-7. PubMed ID: 9035019
[TBL] [Abstract][Full Text] [Related]
33. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
Friedel HA; Langtry HD; Buckley MM
Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
[TBL] [Abstract][Full Text] [Related]
34. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis.
Taha AS; McLaughlin S; Holland PJ; Kelly RW; Sturrock RD; Russell RI
Ann Rheum Dis; 1990 Jun; 49(6):354-8. PubMed ID: 2143369
[TBL] [Abstract][Full Text] [Related]
35. Sucralfate protection against gastrointestinal damage: possible role of prostanoids.
Ligumsky M; Karmeli F; Rachmilewitz D
Isr J Med Sci; 1986 Nov; 22(11):801-6. PubMed ID: 3098700
[TBL] [Abstract][Full Text] [Related]
36. Rectal administration of nonsteroidal antiinflammatory drugs. Effect on rat gastric ulcerogenicity and prostaglandin E2 synthesis.
Ligumsky M; Sestieri M; Karmeli F; Zimmerman J; Okon E; Rachmilewitz D
Gastroenterology; 1990 May; 98(5 Pt 1):1245-9. PubMed ID: 2323517
[TBL] [Abstract][Full Text] [Related]
37. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J
Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837
[TBL] [Abstract][Full Text] [Related]
38. Nabumetone: a clinical appraisal.
Helfgott SM
Semin Arthritis Rheum; 1994 Apr; 23(5):341-6. PubMed ID: 8036523
[TBL] [Abstract][Full Text] [Related]
39. Effects of nimesulide, acetylsalicylic acid, ibuprofen and nabumetone on cyclooxygenase-1- and cyclooxygenase-2-mediated prostanoid production in healthy volunteers ex vivo.
Kerola M; Vuolteenaho K; Kosonen O; Kankaanranta H; Sarna S; Moilanen E
Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):17-21. PubMed ID: 19152549
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
